News & Information

Transplant Living News provides the latest news about pre- and post-transplant therapies, surgical technologies and research in the field of transplantation. Please refer to the news from the past 30 days listed below.


Keyword Search:
Submit Search Help

Articles Published Within Last 30 Days
01/31/2012 US FDA approves once-weekly exenatide for diabetes
 
WASHINGTON (Reuters) - Amylin Pharmaceuticals won U.S. approval on Friday for its once-weekly injectable Bydureon (exenatide extended release) for treating adults with type 2 diabetes, a long-awaited victory for the company's most promising product.
01/25/2012 Kidney-pancreas transplant reverses brain effects of diabetes
 
NEW YORK (Reuters Health) - Many effects of diabetes and end-stage renal disease on the brain are reversed after kidney-pancreas transplantation, according to a report online December 21 in Diabetes Care.
01/24/2012 Even small intraoperative transfusions are detrimental: study
 
NEW YORK (Reuters Health) - The adverse effects of intraoperative blood transfusions are dose-dependent, and even a single unit may worsen outcomes, according to a report this month in Archives of Surgery.
01/17/2012 Once-weekly exenatide similar to daily metformin for type 2 diabetes
 
NEW YORK (Reuters Health) - A direct comparison of four agents as monotherapy in drug-naive patients with type 2 diabetes shows that exenatide once-weekly, metformin, and pioglitazone provide good improvement in glycemic control, while sitagliptin is less effective.
01/11/2012 Heart disease more likely with longer duration of psoriasis
 
NEW YORK (Reuters Health) - People who suffer from psoriasis may be at a greater risk for coronary artery disease, and a new study suggests the heart risks are higher in people who've had psoriasis longer.


Public Comments Published Within Last 30 Days
02/03/2012 New Policy Proposal Available for Public Comment
 
OPTN/UNOS Bylaws Appendix L (previously Appendix A) is now available for public comment.